Benzinga | Oct 27, 2021 05:18PM EDT

Invacare Q3 EPS $(0.12) Beats $(0.19) Estimate, Adj. $18.1M, Sales $224.20M Beat $219.53M Estimate; Reaffirms FY21 Adj. EBITDA $30M-$37M

Invacare (NYSE:IVC) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.19) by 36.84 percent. This is a 20 percent decrease over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $224.20 million which beat the analyst consensus estimate of $219.53 million by 2.13 percent. This is a 5.80 percent increase over sales of $211.91 million the same period last year.